Respiratory System Image $3.8M NIH grant will fund research into potential early COPD biomarker Aug. 14, 2025 BIO5 member Stefano Guerra is leading a $3.8M NIH-funded study to test whether low levels of the lung protein CC16 in childhood can predict early COPD risk in adulthood. Read more in U of A Research and Partnerships Image A tale of two cities and a health mystery April 16, 2025 Multiple BIO5 members lead the BEAMS study, investigating how early-life environmental exposures across the U.S.-Mexico border impact asthma risk. Read more in U of A Health Sciences Image Researchers launch startup to bring novel treatments to patients with asthma and COPD April 16, 2025 BIO5 Members Julie Ledford, Josef Vagner, Stefano Guerra, and Michael D.L. Johnson co-developed an innovative inhaled asthma/COPD therapy licensed to Aspiro Therapeutics. Read more in U of A Health Sciences
Image $3.8M NIH grant will fund research into potential early COPD biomarker Aug. 14, 2025 BIO5 member Stefano Guerra is leading a $3.8M NIH-funded study to test whether low levels of the lung protein CC16 in childhood can predict early COPD risk in adulthood. Read more in U of A Research and Partnerships
Image A tale of two cities and a health mystery April 16, 2025 Multiple BIO5 members lead the BEAMS study, investigating how early-life environmental exposures across the U.S.-Mexico border impact asthma risk. Read more in U of A Health Sciences
Image Researchers launch startup to bring novel treatments to patients with asthma and COPD April 16, 2025 BIO5 Members Julie Ledford, Josef Vagner, Stefano Guerra, and Michael D.L. Johnson co-developed an innovative inhaled asthma/COPD therapy licensed to Aspiro Therapeutics. Read more in U of A Health Sciences
